FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 60 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,686,000 | -26.6% | 506,214 | -33.0% | 0.12% | -41.9% |
| Q3 2019 | $2,298,000 | +27.7% | 755,998 | 0.0% | 0.20% | +25.3% |
| Q2 2019 | $1,799,000 | -36.5% | 755,998 | 0.0% | 0.16% | -25.8% |
| Q1 2019 | $2,835,000 | +4.5% | 755,998 | 0.0% | 0.21% | -9.4% |
| Q4 2018 | $2,714,000 | +610.5% | 755,998 | +980.0% | 0.24% | +552.8% |
| Q3 2014 | $382,000 | – | 70,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|